CNBC-TV18's Archana Shukla reports that India's grant of a compulsory licence to Natco for Bayer's kidney-cancer drug Nexavar has sent shockwaves across the globe
first published: Aug 17, 2012 09:54 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

